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Abstract
Background: Most help-seeking substance abusers have comorbid psychiatric disorders. The
importance of such disorders for the long-term course of substance abuse is, however, still unclear.
The aim of this paper is to describe six-year outcomes regarding death and relapse among
alcoholics and poly-substance abusers and to analyse the predictive value of lifetime psychiatric
disorders on relapse.
Methods: A consecutive sample of substance-dependent patients who received treatment in two
counties in Norway (n = 287) was followed up after approximately six years. Information on socio-
demographics, Axis I (CIDI) and II disorders (MCMI-II) and mental distress (HSCL-25) was
gathered at baseline. At follow-up, detailed information regarding socio-demographics, use of
substances (AUDIT and DUDIT) and mental distress (HSCL-25) was recorded (response rate:
63%).
Results: At six-year follow-up, 11% had died, most often male alcoholics (18%). Among the
surviving patients, 70% had drug or alcohol related problems the year prior to follow-up. These
patients were, classified as "relapsers". There were no significant differences in the relapse rate
between women and men and among poly-substance abusers and alcoholics. The relapsers had an
earlier onset of a substance use disorder, and more frequently major depression and agoraphobia.
Multivariate analysis indicated that both psychiatric disorders (major depression) and substance use
factors (early onset of a substance use disorder) were independent predictors of relapse.
Conclusion: For reducing the risk of long-term relapse, assessment and treatment of major
depression (and agoraphobia) are important. In addition, we are in need of a comprehensive
treatment and rehabilitation program that also focuses on the addictive behaviour.
Background
Most help-seeking substance abusers have comorbid
symptom disorders and/or personality disorders [1-3].
The importance of such disorders for the long-term course
of substance abuse is, however, still unclear. Most studies
to date have examined the relationship between psychiat-
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ric disorders and substance use outcomes only in short-
term follow-up studies [4,5]. The few long-term studies (>
5 years) of comorbid disorders among cocaine abusers
[6], opiate abusers [7-11] and alcoholics [12-15] are
mainly from single treatment institutions and examine
samples with alcoholics or drug addicts only, or males
and females separately [4]. Consequently, there is a need
for outcome studies in clinically representative samples
that differentiate between genders as well as between alco-
holics and poly-substance abusers, and that include both
measures of substance abuse and Axis I (symptom disor-
ders) and Axis II (personality disorders) disorders. By con-
trolling for socio-demographic and substance use factors,
such studies may clarify whether lifetime Axis I and II dis-
orders have a unique and independent impact on the
long-term course of substance abuse. If they have such an
impact, it may have important implications for treatment
planning [16].
We have conducted a six-year prospective study of a con-
secutive sample of patients who received treatment for
substance abuse in two counties in Norway between 1997
and 1998 (n = 287). At baseline, extensive information
about socio-demographics, substance use factors, psychi-
atric disorders (Axis I and II disorders) and mental distress
were gathered through personal interviews and self-
reports. At follow-up, detailed information about socio-
demographics, substance use and mental distress was
recorded through a postal questionnaire. "Relapsers" were
defined as persons with drug- or alcohol-related problems
at both follow-up and over the preceding year. Baseline
variables were analysed as predictors of "relapse".
This paper explores the following research questions:
1. What is the frequency of death and relapse at the six-
year follow-up in the total sample, as well as among the
sub-groups of poly-substance abusers and alcoholics? Do
possible gender differences exist in and between the two
sub-groups?
2. Is there any difference between abstainers and relapsers
with regard to socio-demographic variables, substance use
variables and Axis I and II disorders? Are there differences
within poly-substance abusers and alcoholics?
3. Are lifetime Axis I and II disorders assessed at baseline
independent predictors of relapse at follow-up, when con-




A consecutive sample (n = 287, 73% male, mean age 38.6
± 11.3 years) of DSM-IV substance-dependent patients
(156 alcoholics and 131 poly-substance-dependent) from
three outpatient (n = 157) and six inpatient (n = 130)
public substance abuse facilities in two Norwegian coun-
ties were recruited from September 1997 to November
1998. These facilities were owned or financed by the two
counties. In the six-inpatient units, there were two thera-
peutic communities, one shelter, one short-term unit (6
weeks) and two long-term units (between 3 months and
11/2 year). Two of the inpatient units were for males, and
one of the units was for females. The therapeutic commu-
nities offered treatment to young drug addicts. The pro-
grams had abstinence and rehabilitation as their primary
goal and they offered both individual and group therapy.
Few of the programs assessed and specifically treated diag-
nosed psychiatric disorders. Treatment in most of the pro-
grammes was not based on a specific ideology or
philosophy. The three outpatient units offered primarily
individual therapy and the main goal for treatment was
abstinence and rehabilitation.
The participation rate was 42% (287/690). Those who
were recruited and those who did not participate did not
differ significantly with regard to socio-demographic vari-
ables and substance use variables except for age. Our sam-
ple was somewhat older (38.6 vs. 35.6; p < 0.001). To
evaluate further whether our sample was representative,
we compared our sample with a national sample (n =
5,000), drawn from the nationwide treatment system in
Norway (17). Our sample was older (23% vs. 36% were
younger than 30 years, p < 0.001), more often married/
cohabiting (36% vs. 27%, p = 0.02), and more frequently
using alcohol (63% vs. 50%, p < 0.001), and less fre-
quently using heroin (16 vs. 21%, p < 0.05). In general,
the sample appeared somewhat skewed towards having
fewer young drug addicts compared with the national
sample. Further information about sampling, subjects,
and methods has been described elsewhere (3). All
patients gave written informed consent to assessment at
admission and to be contacted at a six-year follow-up.
A follow-up study of the same sample (n = 287) was con-
ducted on average 75 months (SD = 5.0) later (July to
November 2004). At this time, 33 patients (11%) had
died. Attempts were made to contact the remaining
patients (n = 254) by telephone to inquire if they wanted
to participate in the follow-up study. A questionnaire was
then mailed to them. They received 300 Norwegian kro-
ner for completing the form (approximately 38 EURO). In
all, 160 patients (63% of the surviving participants)
answered the questionnaire. Of the group who did not
respond (n = 94), 14 refused participation, 23 were not
located, and 57 received the assessment form twice
(according to instructions from the Norwegian Data
Inspectorate) but did not answer it. When including the
deceased patients, the participation rate was 67% (193/BMC Psychiatry 2006, 6:44 http://www.biomedcentral.com/1471-244X/6/44
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287). In the analyses, living and deceased patients were
analysed separately.
When comparing the participants (n = 160) with the non-
participants (n = 94), there were no significant differences
with regard to socio-demographics, substance use varia-
bles, Axis I and II disorders, mental distress (HSCL-25),
inpatient or outpatient status, and treatment history at
baseline.
Subjects
At baseline, all subjects met DSM-IV criteria for current
substance dependence or abuse. Fifty-four percent (n =
156) of the subjects were classified as pure alcoholics, i.e.
a diagnosis of alcohol dependence with no other drug-
dependence or abuse. Forty-six percent (n = 131) were
classified as poly-substance abusers, all being dependent
on illicit drugs. Of these, 85% used heroin and/or
amphetamine as the primary substance of abuse. In addi-
tion, 35% of the poly-substance abusers fulfilled the crite-
ria for current alcohol dependence or abuse. The mean
number of illicit drugs on which poly-substance abusers
were currently dependent was 3.9 (SD = 2.1).
Measures at baseline
The patients were assessed using the Norwegian National
Client Assessment form [17] (socio-demographic, treat-
ment history), the Composite International Diagnostic
Interview (CIDI) [18] (lifetime and current Axis I disor-
ders, including both psychiatric disorders and substance
use disorders), and two self-report questionnaires: the
Millon Clinical Multiaxial Inventory (MCMI-II) [19] (Axis
II disorders) and the Hopkins Symptom Checklist 25
(HSCL-25) (mental distress) [20].
A diagnosis for substance abuse, harmful use or depend-
ence was assessed using the CIDI (based on DSM-IV and
ICD-10 criteria). The CIDI was also used to classify the
patient's main substance of abuse as either alcohol
dependence with no other drug dependence or abuse, or
as poly-substance dependence. In addition, the patients
reported the number of alcohol units used on a typical
drinking day during the last 12 months.
The CIDI interviews were primarily conducted by the two
researchers (K.B. and A.L.) who took part in the training
workshops offered by The National WHO Training Centre
in Munich. One third of the interviews for this study were
conducted by trained clinicians (psychiatrists, social
workers, psychiatric nurses), who had been trained by
K.B. and A.L. in a standardised 4-day training program.
The CIDI has shown good feasibility in general popula-
tions, high inter-rater reliability and has been subjected to
tests of reliability and validity with satisfactory results
[21].
Findings from several studies of the psychometric proper-
ties of the MCMI-II report acceptable test-retest reliability
and generally acceptable levels of convergent and discri-
minant validity of the scales [22]. In the baseline study,
the HSCL-25 showed excellent reliability with a Cron-
bach's alpha of 0.94.
Measures at follow-up (postal questionnaire)
The follow-up questionnaire covered socio-demographics
and treatment history using the same questions that were
used at baseline (The Norwegian National Client Assess-
ment form).
Due to a lack of resources, we did not have the opportu-
nity to conduct personal interviews (i.e.- the CIDI) to
make psychiatric diagnoses and evaluate substance use
disorders at follow-up. In stead, we used well-established
self-report instruments (AUDIT, DUDIT and HSCL-25).
Mental distress during the week immediately prior to
assessment was measured using the HSCL-25 (as at base-
line). Reliability according to Cronbach's alpha for HSCL-
25 at follow-up was 0.96.
To measures substance use we used the Alcohol Use Dis-
orders Identification Test (AUDIT) [23] and the Drug Use
Disorders Identification Test (DUDIT) [24]. Both are
screening instruments for identifying persons with a prob-
lematic use of substances during the previous 12 months.
Both instruments are standardized and based on selected
criteria for substance abuse, harmful use and dependence
according to the ICD-10 and DSM-IV diagnostic systems.
The AUDIT core questionnaire consists of 10 items: three
questions on quantity and frequency of drinking, three
items on alcohol dependence and four questions on prob-
lems caused by drinking. Weighted scoring with respect to
the frequency or the time of occurrence comprises a total
score that ranges from 0 to 40. Standard instructions state
that a total score of eight or more for men and six or more
for women indicates a strong likelihood of hazardous
alcohol consumption. In a review of the AUDIT by Reinert
and Allen (2002) [25], the median sensitivity for identify-
ing individuals with alcohol dependence or misuse was
0.86 and the median specificity was 0.89. In our study,
reliability according to Cronbach's alpha was 0.93.
DUDIT is an 11-item self-report instrument intended for
use together with the AUDIT. The DUDIT's cut-off points
for drug-related problems are scores of six or more for
men and two or more for women out of a maximum of 44
points. The psychometric properties of the DUDIT were
evaluated in a sample of heavy drug users from prison,
probation, and in a general Swedish population sample.
In the drug users sample, the DUDIT predicted drugBMC Psychiatry 2006, 6:44 http://www.biomedcentral.com/1471-244X/6/44
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dependence with a sensitivity of 90% for both DSM-IV
and ICD-10 criteria and a respective specificity of 78%
and 88% [24]. In our study, reliability according to Cron-
bach's alpha was 0.95.
In addition to the AUDIT and DUDIT, the questionnaire
also asked: 1) How many months have you been totally
abstinent from any substances from baseline to follow-
up? And 2) How many alcohol units did you use on a typ-
ical drinking day in the last 12 months before assessment?
Data of deceased patients were provided by the National
Register of Demographical Data. Death certificates (causes
of death) were obtained from the Cause of Death Registry
(Division for Health Statistics in Statistics Norway).
The study protocol at both baseline and follow-up was
reviewed and approved by the Regional Committee for
Medical Research Ethics and by the Norwegian Data
Inspectorate.
Dependent variable: abstainer or relapser
Subjects were classified into one of two groups, abstainers
or relapsers, based on AUDIT and DUDIT scores. The
"abstainers" (n = 48) consisted of persons without any
drug- or alcohol-related problems at follow-up and dur-
ing the 12 months prior to follow-up (based on an AUDIT
score below eight points for men and six points for
women and a DUDIT score below six for men and two for
women). The "relapsers" (n = 112) consisted of persons
with drug- or alcohol-related problems during the year
prior to and at follow-up (based on an AUDIT score ≥ 8
for men and ≥ 6 for women, or a DUDIT score ≥ 6 for men
and ≥ 2 for women).
Independent variables
Potential risk factors assessed at baseline were selected
according to the literature [5]. They consisted of: socio-
demographics (age, sex, marital status and employment
status), substance use variables (main substance of abuse,
age at onset of a substance use disorder, duration of a sub-
stance use disorder and mean number of lifetime sub-
stance use disorder diagnoses) and psychiatric disorders
(any lifetime Axis I disorders, number of lifetime Axis I
disorders, single lifetime Axis I disorders, any personality
disorders, number and type of personality disorders).
Lifetime instead of current Axis I disorders were selected as
a possible predictors of relapse. The reason for this choice
was that lifetime Axis I disorders and current Axis I disor-
ders were highly correlated. In addition, current Axis I dis-
orders seem to be more related to the situation at
assessment and we assume that lifetime disorders are
more valid with regard to the disposition for Axis I disor-
ders. Results by current Axis I disorders are presented in
the results section but were not examined as potential pre-
dictors of relapse.
Statistical analysis
The data were analysed in two steps. First, univariate com-
parisons were made between groups using chi-square tests
for categorical data, independent t-tests for continuous
variables and paired t-tests for continuous variables at
baseline vs. follow-up. Second, a prognostic strategy was
used to analyse the predictive value of lifetime psychiatric
disorders on relapse at follow-up. A logistic regression
model was used to identify the odds ratio of all explana-
tory variables (covariates) that were significant in the uni-
variate analyses. The dependent variable in the regression
model was the substance use outcome at follow-up
(relapser = 1, abstainer = 0). A correlation analysis was
done between the major covariates used in the model. If
covariates were highly correlated (r > 0.40), we selected
one of them for the model. We used a backward elimina-
tion procedure in the logistic regression model and
checked the goodness of fit via chi-square using the Hos-
mer and Lemeshow goodness-of-fit test [26]. All analyses




At the six-year follow-up, 11% of the original sample had
died (33/287); information regarding causes of death was
obtained for 26 patients. In 21 of the patients, death was
substance-related (overdose, poisoning, alcoholic cirrho-
sis of the liver, toxic effect of alcohol). Among the remain-
ing five patients, two died from cancer, one from suicide
and for two patients the cause of death was unknown.
Selected baseline characteristic measures were used to
compare the 160 surviving persons and the 33 deceased
persons (Table 1). At baseline, the since-deceased patients
were older (44.2 vs. 38.7 years, p = 0.01), more frequently
alcoholics (73% vs. 54%, p = 0.04) and more likely to
have a later onset of a substance use disorder (mean age of
onset, SUD: 26.4 vs. 22.3 years, p = 0.03).
Male alcoholics had the highest percentage of deaths (n =
22/121, 18%) compared to female alcoholics (n = 2/35,
6%) and female (n = 4/44, 9%) and male (n = 5/87, 6%)
poly-substance abusers (p = 0.05). The mean age of male
alcoholics when they died was 51.5 years old (SD = 10.6),
while it was 49.5 years (SD = 9.1) in female alcoholics. In
deceased male poly-substance abusers, the mean age was
39.5 years (SD = 3.5) while deceased female poly-sub-
stance abusers had a mean age of 38 years (SD = 9.2) at the
time of death. The age difference at death between alco-
holics and poly-substance abusers was significant (38 vs.
51, p = 0.01).BMC Psychiatry 2006, 6:44 http://www.biomedcentral.com/1471-244X/6/44
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The observed death rate each year for the total sample is
1.9%, 3% among male alcoholics, 1% in female alcohol-
ics, 1% in male poly-substance abusers and 1.5% among
female poly-substance abusers.
Substance use outcome among the surviving patients
Of the surviving patients who participated at follow-up,
30% (48/160) were abstainers and 70% (112/160) had
relapsed according to their AUDIT and DUDIT scores. The
mean score on the AUDIT for abstainers was 2.2 (SD =
2.5) and the mean score for the DUDIT was 0.33 (SD =
0.9). The mean number of months of total abstinence
from any substances between baseline and follow-up was
53.2 months (SD = 27.5), with a median of 57 months.
Fifty-two per cent (n = 25) of the abstainers had been
totally abstinent from any substances for five years or
more.
Seventy per cent were relapsers (n = 112) at follow-up as
well as over the previous year. The mean AUDIT score for
relapsers was 18.2 (SD = 8.6) and the mean DUDIT score
was 16.9 (SD = 9.8). The mean number of months of total
abstinence from any substances between baseline and fol-
low-up was 20.9 months (SD = 20.8), with a median of 14
months. From baseline to follow-up 43% (n = 48) of the
relapsers had been totally abstinent for 11 months or less.
At both baseline and follow-up, the patients reported the
number of alcohol units used on a typical drinking day in
the last 12 months. When comparing the mean units of
alcohol used at baseline and follow-up in abstainers
(paired sample t-test), we found a significant decrease
from 16.6 (± 8.5 (SD) alcohol units to 7.0 (± 4.4) alcohol
units (p = 0.001). In relapsers, we found no significant
decrease in the use of alcohol from baseline to follow-up
(mean number of alcohol units used on a typical drinking
day = 18.3 units ± 11.8 vs. 16.3 units ± 13.0, p = 0.28).
There were no significant gender differences in and
between poly-substance abusers and alcoholics with
regard to relapse rate at follow-up (female alcoholics,
24%; male alcoholics, 32%; female poly-substance abus-
ers, 35%; male poly-substance abusers, 27%, p = 0.80).
Among the poly-substance abusers, 28 received metha-
done treatment during the follow-up period and at fol-
low-up. There was no significant difference in relapse rate
between poly-substance abusers with or without metha-
done treatment (79% vs. 65%, p = 0.22). Relapsers on
methadone treatment were using mainly illicit drugs
rather than alcohol.
Comparisons of abstainers and relapsers
Table 2 shows that the relapsers were younger (37.7 years
vs. 41.2 years, p = 0.06) and less often married or cohab-
iting at both baseline (33% vs. 51%, p = 0.04) and follow-
up (31% vs. 54%, p = 0.01) as, compared to abstainers.
Additionally, relapsers differed significantly from abstain-
ers by having an earlier onset of a substance use disorder
(52% vs. 31%, onset SUD before the age of 18, p = 0.01).
There were no significant differences between abstainers
and relapsers on whether they received treatment in out-
patient or inpatient facilities at baseline (52% vs. 56%, p
= 0.63). The relapsers had more often received treatment
in the substance abuse field (75% vs. 54%, p = 0.01) and
in the mental health care system (55% vs. 40%, p = 0.06)
between baseline and follow-up, compared to abstainers.
With regard to comorbid psychiatric disorders, Table 3
shows that lifetime Axis I disorders were more common
among relapsers as compared to abstainers (94% vs. 83%,
p = 0.03). In particular, relapsers had higher rates of major
depression (51% vs. 34%, p = 0.05), agoraphobia (50%
vs. 33%, p = 0.05) and a higher number of Axis I disorders






Female, % 29 18 0.19
Age, mean years (SD) 38.7 (11.0) 44.2 (10.1) 0.01
Employment, % 34 29 0.60
Marital status, % 39 30 0.37
Alcoholics, % 54 73 0.04
Onset of substance use disorder, mean years (SD) 22.3 (9.9) 26.4 (12.5) 0.03
Duration of substance use disorder, mean years (SD) 16.4 (9.1) 17.7 (9.1) 0.45
Lifetime Axis 1 disorder, % 91 82 0.13
Lifetime anxiety disorders, % 81 81 0.95
Lifetime affective disorders, % 64 52 0.19
Any personality disorder, % 72 73 0.90BMC Psychiatry 2006, 6:44 http://www.biomedcentral.com/1471-244X/6/44
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(mean number: 3.9 vs. 2.8, p = 0.01). Any current Axis I
disorders were significantly more frequent among
relapsers than abstainers (88% vs. 75%, p = 0.04). Fur-
thermore, current major depression tended to be more
frequent among relapsers than abstainers (40% vs. 29%,
p = 0.18). Results regarding current Axis I disorders had
the same direction as lifetime disorders but given the
smaller number of patients with a current disorder the
results did not reach significance.
Relapsers also had a significantly higher mental distress
score at follow-up compared with abstainers (mean score
on HSCL-25: 2.17 vs. 1.52, p = 0.001). There were no sig-
nificant differences between relapsers and abstainers with
regard to frequency and type of personality disorders
(Table 4).
When doing the analyses separately among alcoholics and
poly-substance abusers, the only difference between the
two subgroups was that relapsers had an earlier onset of a
substance use disorder compared to abstainers in poly-
substance abusers (81% vs. 50%, p = 0.01, onset before 18
years old) but not in alcoholics (27% vs. 15%, p = 0.25).
Independent predictors of relapse at follow-up
To identify whether lifetime psychiatric disorders had an
independent impact on being a relapser at follow-up, a
logistic regression analysis was conducted. The dependent
variable was relapser = 1, abstainer = 0. As independent
variables, we included those baseline variables that were
significant or nearly significant in univariate analyses in
Tables 2, 3 and 4 (age, marital status, onset of a substance
use disorder, lifetime major depression and agorapho-
bia). Age was excluded from further analyses because it
was highly correlated with onset of a substance use disor-
der (r = 0.61). The following covariates were included in
the model: marital status (1 = married/cohabited and 0 =
not married/cohabited), age at onset of a substance use
disorder (1 = below 18 years and 0 = 18 years or older),
major depression (1 = yes and 0 = no) and agoraphobia (1
= yes and 0 = no). Next, we used a backward elimination
procedure in the logistic model and checked the goodness
of fit using chi-square via the Hosmer-Lemeshow test. We
excluded agoraphobia and marital status from the model
because the goodness-of-fit test was higher by including
only major depression and onset of a substance use disor-
der (Hosmer-Lemeshow: chi-square = 3.52, df = 8, p =
0.89 vs. chi-square = 0.02, df = 2, p = 0.95).
In Table 5, the final model shows that there are two signif-
icant independent predictors of being a relapser at follow-
up: an early onset of a substance use disorder (OR = 2.3, p
= 0.02) and the occurrence of a lifetime major depression
(OR = 2.1, p = 0.05). The two predictors remained signif-
Table 2: Socio-demographic variables (A), substance abuse variables (B) treatment variables (C) at baseline (T1) and follow-up (T2) 
between abstainers and relapsers.
A. Socio-demographic variables Abstainers N = 48 Relapsers N = 112 p-value
Sex, female, T1, % 29 30 0.97
Age, mean years (SD), T1 41.2 (11.8) 37.7 (10.6) 0.06
Employment, %
T1 38 32 0.48
T2 35 26 0.22
Marital status, married or cohabiting, %
T1 51 33 0.04
T2 54 31 0.01
B. Substance abuse variables Abstainers N = 48 Relapsers N = 112 p-value
Poly-substance abusers, T1, % 46 46 0.94
Onset of SUD, < 18 years, T1 % 31 52 0.01
Duration of SUD, ≥ 15 years, T1 % 50 59 0.29
Mean number of lifetime SUD diagnoses (abuse and dependence), T1 2.2 (1.6) 2.6 (2.1) 0.25
C. Treatment variables Abstainers N = 48 Relapsers N = 112 p-value
In-patients facilities, T1, % 52 56 0.63
Out-patient facilities, T1,% 48 44
Treatment in the substance abuse field, prior to T1, % 60 72 0.14
Treatment in the mental health care system, prior to T1, % 36 39 0.75
Treatment in the substance abuse field, between T1 and T2, % 54 75 0.01
Treatment in the mental health care system, between T1 and T2, % 40 55 0.06BMC Psychiatry 2006, 6:44 http://www.biomedcentral.com/1471-244X/6/44
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icant after controlling for gender and main substance of
abuse (alcoholics vs. poly-substance abusers).
Discussion
Outcome at six-year follow-up
By the six-year follow-up, 11% had died, most of whom
were male alcoholics. In two-thirds of these deaths, the
cause of death was substance-related. The yearly death rate
of approximately 2% is quite similar to other studies of
substance-dependent persons [27-30], and higher than in
the general population in Norway in 2004 (0.9%). The
yearly death rate in the sample is higher both for women
(1.3%, mean age at T1: 36 years) and men (2.1%, mean
age at T1: 39) compared with yearly death rates among
women (0.06%) and men (0.1%) in the general popula-
tion between 35–39 years [31]. The observed death rate
each year for male alcoholics was approximately 3% com-
pared to 0.4% among men in the same age group (50–54
years) in the general population in 2004. Our findings
indicate that chronic alcohol dependence in men may
lead to premature death, and the importance of this may
be overlooked in short-term studies.
Among surviving patients, 70% (n = 112/160) still had
drug- or alcohol-related problems at follow-up and over
the year immediately prior to follow-up (relapsers). In
relapsers, there was no significant decrease in use of alco-
hol between baseline and follow-up.
Studies with comparable follow-up intervals (5–8 years)
have reported relapse rates in alcoholics that lie between
45% and 75% [11,12,29,32-37] and in illicit drug abusers
(mainly opiates) between 39% and 84% [6,8,30,38-44].
In many studies, including ours, it is between 60% and
70%.
There were no significant differences between poly-sub-
stance abusers and alcoholics with regard to relapse rate.
In different studies the relapse rate usually are higher
among poly-substance abusers than among alcoholics [4].
However, more alcoholics died in the current study.
Methadone programs started after 1998 in Norway. The
main goal of methadone treatment was to eradicate the
use of heroin and other illicit drugs. One would expect to
find that patients on methadone treatment (n = 28) were
more abstinent at the six-year follow-up than poly-sub-
stance abusers without such treatment. The results are not
in the expected direction (79% vs. 65%, p = 0.22).
There are few studies comparing relapse rate between
female and male substance abusers within the same sam-
ple. A recent review concluded that women had treatment
outcomes that were as good as or better than those of men
[45]. In the present study, there was no significant differ-
ence in relapse rate between women and men.
Predictors of relapse: socio-demographic and substance 
abuse variables
The relapsers were younger, more seldom married or
cohabiting and had an earlier onset of a substance use dis-
order. These findings concur with the literature
[5,6,15,30,34].
An early onset of a substance use disorder had an inde-
pendent impact on being a relapser at follow-up, after
controlling for main substance of abuse (alcoholics and
poly-substance abusers) and Axis I disorders. This is in
accordance with other studies showing that an early onset
of a substance use disorder often leads to a poor substance
use outcome and is a valid measure of severity of sub-
stance abuse [5].
The early onset of a substance use disorder may lead to the
rapid progression of abuse and dependence and social
disintegration, and the way back to social integration and
Table 3: Lifetime Axis I disorders and mental distress at follow-up between abstainers and relapsers.
Axis I disorders Abstainers N = 48 Relapsers N = 112 p-value
Any Axis I disorder, % 83 94 0.03
Affective disorders, % 55 67 0.15
Major depression, % 34 51 0.05
D y s t h y m i a ,  % 3 03 90 . 2 8
All anxiety disorders, % 75 84 0.19
*Agoraphobia, % 33 50 0.05
Social phobia, % 40 51 0.20
Simple phobia, % 40 48 0.39
Post traumatic stress disorder, % 21 22 0.89
Somatization disorder, % 28 28 0.99
Number of Axis I disorders, mean (SD) 2.8 (2.0) 3.9 (2.7) 0.01
Mental distress, HSCL-25, mean (SD)
T2
1.52 (0.5) 2.17 (0.5) 0.001
*Agoraphobia with and without panic attackBMC Psychiatry 2006, 6:44 http://www.biomedcentral.com/1471-244X/6/44
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sobriety may be more difficult. To become more socially
integrated and reduce the risk of relapse, such persons are
in great need of psychosocial treatment and the availabil-
ity of good rehabilitation programs.
Predictors of relapse: comorbid psychiatric disorders
Concerning Axis I disorders, relapsers had more lifetime
Axis I disorders and especially more major depression and
agoraphobia (assessed at baseline). Subjects with a life-
time major depression were significantly more likely to be
relapsers at six-year follow-up, even after controlling for
socio-demographic factors, agoraphobia and substance
use variables. These results were significant both in alco-
holics and in poly-substance abusers.
The predictive value of major depression on relapse in
long-term studies has not been consistent in either studies
of alcoholics or illicit drug abusers. Different characteris-
tics of the samples, different measures and additional var-
iables such as further treatment or social network and
support may influence the relationship between major
depression and relapse.
One long-term follow-up study of alcoholics [30] found
that depression predicted heavier alcohol consumption at
follow-up but only among women. Another study [46]
found that depression and drinking outcomes were signif-
icantly related at the three-year follow-up. Furthermore,
Kranzler et al. (1995) [47] found that major depression
was associated with lower intensity of drinking at three-
year follow-up. Thus, our data regarding alcoholics are
supported by other studies.
In long-term studies of illicit drug abusers, Verthein et al.
(2005), [9] showed in their four-year follow-up study of
opiate-dependent patients that lifetime diagnosis of men-
tal disorders had no prognostic relevance for the long-
term course of drug dependency. In another five-year fol-
low-up study of opiate users, depression predicted less
drug use in the year preceding follow-up, whereas greater
hostility predicted increased drug use [7]. Ravndal and
Vaglum (1998) [11] found in their five-year follow-up
study of drug abusers that personality disorders and psy-
chopathology did not directly predict substance use out-
come. Except for our study and the study by Verthein,
these studies are from single treatment institutions and
not from a heterogenic sample derived from a catchment
area. Our findings concerning illicit drug abusers, there-
fore, need replication in further studies of clinically repre-
sentative samples.
Major depression is a frequent disorder among treatment-
seeking substance abusers. In our sample, 46% fulfilled
the criteria for such a disorder and there was no significant
difference between rates among poly-substance abusers
and alcoholics. In 68% of those with a lifetime major
depression, the disorder occurred for the first time at least
one year after the debut of a substance use disorder (sec-
ondary depressive disorder). There was, however, no sig-
nificant difference in relapse rate between subjects
developing major depression before or after the onset of a
substance use disorder. Consequently, both primary and
secondary major depressions should be addressed in treat-
ment.
Relapsers with a lifetime major depressive disorder
assessed at baseline had a higher mental distress score at
follow-up compared to relapsers without such a disorder
(mean score on HSCL-25 = 2.28 ± 0.57 (SD) vs. 2.07 ±
0.55, p = 0.06). Also, 63% of relapsers with a lifetime
major depression had received treatment in the mental
health care system between baseline and follow-up, com-
pared to 50% in relapsers without a lifetime major depres-
sion (p = 0.18). These findings support the notion that the
lifetime major depression identified at baseline indicates
a chronic condition that continues to influence the
patient into the future. Consequently, it is important to
address simultaneously both depression (and agorapho-
Table 4: Lifetime Axis II disorders between abstainers and 
relapsers. MCMI-II, Base rate score ≥ 85.





Any personality disorder, % 71 73 0.84
Paranoid, % 2 5 0.48
Schizoid, % 11 19 0.25
Schizotyp, % 7 16 0.12
Antisocial, % 30 32 0.73
Borderline, % 25 34 0.26
Histrionic, % 11 11 0.99
Narcissistic, % 11 13 0.74
Avoidant, % 30 42 0.16
Dependent, % 21 17 0.63
Compulsive, % 9 4 0.19
Passive-aggressive, % 39 40 0.88
Self-defeating, % 18 30 0.15
Aggressive- Sadistic, % 18 25 0.38
Number of Axis II disorders, 
mean (SD)
2.3 (2.0) 2.8 (2.7) 0.25
Table 5: Predictors of relapse at six-year follow-up. Odds ratio 
(OR) and 95% confidence intervals (CI) (n = 160).
Predictors OR 95% CI p-value
Onset of SUD, before 18 years
(0 = no, 1 = yes)
2.3 1.14–4.96 0.02
Major depression (0 = no, 1 = yes) 2.1 1.10–4.51 0.05
Hosmer-Lemeshow goodness-of-fit test; chi-square = 0.02, df = 2, p = 
0.95BMC Psychiatry 2006, 6:44 http://www.biomedcentral.com/1471-244X/6/44
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bia) and the addictive behaviour in the same programme
[48]. Both pharmacological and behavioural interven-
tions have been shown to increase abstinence rates in
patients with combined depression and substance use dis-
orders [49]. Unfortunately, patients with both psychiatric
disorders and a substance use disorder often receive treat-
ment from two parallel treatment systems [48].
A recent review of personality disorders and substance
abuse indicated that the course and outcome of substance
abuse was very often directly and negatively related to the
presence of one or more personality disorders [50]. Our
results do not confirm such a relationship, neither in uni-
variate nor in multivariate analysis. In the cited review
[48], however, nearly all of the studies were short-term (6
months-2 years). The question of the long-term impact of
personality disorders on substance abuse needs further
research.
Strength and limitations
The strength of the current study is the consecutive sample
based on a treatment population, the heterogeneity of
treatment institutions included and the heterogeneity of
the sample by including both poly-substance abusers and
alcoholics. The use of structured interviews and standard-
ized rating scales and self-report instruments with good
and well established reliabilities are also strengths.
The study has some limitations. As in all clinical studies,
it is unclear how representative the sample is and how
context-dependent the results are. The study population is
treatment seeking substance abusers receiving treatment
in the substance abuse field in two counties in Norway.
Our response rate of 63% is acceptable for a long-term fol-
low-up study. There were no significant differences with
regard to socio-demographics, substance use variables,
Axis I and II disorders, mental distress, in-patient or out-
patient status, and treatment history assessed at baseline
between the participants in the follow-up study (n = 160)
and the refusers at follow-up (n = 94). It is hard to say
whether those who did not participate in the follow-up
study have relapsed or remained unimproved. We know
that 24% of the dropouts were not located which means
that they had no stable residence. This may indicate that
they are unimproved and that the relapse rate is underes-
timated.
Although the response rate at 6-year follow-up is accepta-
ble, the 42% response rate at intake was lower than
desired and the sample appeared somewhat skewed
towards having fewer young poly-substance abusers com-
pared with a national sample [17]. Further, we found in
the follow-up study that relapsers were younger than
abstainers. A higher amount of young drug addicts in both
the index-sample and the follow-up sample may have
increased the relapse rate.
Other factors besides personal characteristics at baseline
may also influence relapse, such as important life events,
treatment received and social stability factors. Also, we
were not able to examine stability or temporal changes in
use of substances. Unfortunately, we did not have any
information about the nature of treatment or the patients'
compliance with treatment. Because of the long-term fol-
low-up period, it is difficult to analyse the effect of treat-
ment received at index-admission on substance use
outcome. Many of the patients had received treatment in
the substance abuse field and the mental health care sys-
tem both before and after baseline.
The validity of recall and self-report remains a major prob-
lem in this type of research, especially in long-term stud-
ies. Different studies have showed that self-reports in
substance abusers may constitute a valid instrument for
assessing substance abuse outcome [51]. In the present
study, we have used standardized instruments for assess-
ing substance use outcome. At baseline, we assessed diag-
noses for abuse and dependence by using a structured
interview (CIDI). At follow-up, we used screening tools
for assessing dependence and abuse (AUDIT and DUDIT).
These screening tools have shown a high sensitivity and
specificity for identifying abuse and dependence. In addi-
tion, the patients' answers about use of substances will not
have any influence on their possibility of receiving treat-
ment or other social welfare goods.
Conclusion
In conclusion, at six-year follow-up 11% of the partici-
pants had died, with male alcoholics having the highest
percentage of deaths (18%, n = 22). Among surviving
patients, 70% (n = 112) had relapsed. There were no sig-
nificant differences in the relapse rate between women
and men or between poly-substance abusers and alcohol-
ics. Relapsers had significantly more lifetime Axis I disor-
ders, especially major depression and agoraphobia.
Multivariate analysis indicated that lifetime major depres-
sion and an early onset of a substance use disorder were
independent predictors for relapse, both among alcohol-
ics and among poly substance abusers. For reducing the
long-term risk of relapse, the assessment and treatment of
major depression (and agoraphobia) in substance abusers
is important. Furthermore, we are in need of a compre-
hensive treatment and rehabilitation program that also
focuses on the addictive behaviour.
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